➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
Johnson and Johnson
Medtronic
Express Scripts

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Tocotrienol

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Tocotrienol?

Tocotrienol is an investigational drug.

There have been 22 clinical trials for Tocotrienol. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.

The most common disease conditions in clinical trials are Ovarian Neoplasms, Pancreatic Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are Vejle Hospital, H. Lee Moffitt Cancer Center and Research Institute, and Texas Tech University Health Sciences Center.

There are thirty-one US patents protecting this investigational drug and two hundred international patents.

Recent Clinical Trials for Tocotrienol
TitleSponsorPhase
A Randomized, Double-Blind, Placebo-Controlled Study, to Assess the Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)Hovid BerhadPhase 2
A Randomized, Double-Blind, Placebo-Controlled Study, to Assess the Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)Monash University MalaysiaPhase 2
A Randomized, Double-Blind, Placebo-Controlled Study, to Assess the Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)Yuen Kah HayPhase 2

See all Tocotrienol clinical trials

Clinical Trial Summary for Tocotrienol

Top disease conditions for Tocotrienol
Top clinical trial sponsors for Tocotrienol

See all Tocotrienol clinical trials

US Patents for Tocotrienol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tocotrienol   Start Trial Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders Bristol-Myers Squibb Company (New York, NY)   Start Trial
Tocotrienol   Start Trial Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders Bristol-Myers Squibb Company (New York, NY)   Start Trial
Tocotrienol   Start Trial Antioxidant compositions for coating substrates, substrates coated with the same and methods for inhibiting the oxidation of such compositions applied to a substrate PPG Industries, Inc. (Pittsburgh, PA)   Start Trial
Tocotrienol   Start Trial Substrates coated with antioxidant compositions and method for inhibiting the oxidation of such compositions applied to a substrate PPG Industries, Inc. (Pittsburgh, PA)   Start Trial
Tocotrienol   Start Trial Stabilizer in solid form for organic polymers Great Lakes Chemical (Europe) GmbH (Fraunfeld, CH)   Start Trial
Tocotrienol   Start Trial Tocotrienols and tocotrienol-like compounds and methods for their use Lipogenics, Inc. (Phoenix, AR)   Start Trial
Tocotrienol   Start Trial Tocotrienols and tocotrienol-like compounds and methods for their use Lipogenics, Inc. (Phoenix, AZ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tocotrienol

Drugname Country Document Number Estimated Expiration Related US Patent
Tocotrienol Canada CA2026713 2009-10-04   Start Trial
Tocotrienol European Patent Office EP0421419 2009-10-04   Start Trial
Tocotrienol Hungary HU207442 2009-10-04   Start Trial
Tocotrienol Hungary HU906297 2009-10-04   Start Trial
Tocotrienol Hungary HUT54887 2009-10-04   Start Trial
Tocotrienol Israel IL95857 2009-10-04   Start Trial
Tocotrienol Japan JPH03246222 2009-10-04   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
Johnson and Johnson
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.